| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director | Common Stock | 6.56K | $85.7K | $13.07 | May 15, 2024 | Direct |
| INOVIO PHARMACEUTICALS, INC. | Director | Restricted Stock Unit | 2.17K | $28.3K | $13.07 | May 21, 2024 | Direct |
| LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | Dec 12, 2024 | Direct |
| 89bio, Inc. | Director | Stock Option (Right to Buy) | 45.2K | Feb 1, 2024 | Direct | ||
| Zymeworks Inc. | Director | Stock Option (Right to Buy) | 25K | Dec 21, 2022 | Direct | ||
| enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 15, 2024 | Direct | ||
| Zymeworks Inc. | Director | Stock Option (Right to Buy) | 9K | May 6, 2021 | Direct | ||
| INOVIO PHARMACEUTICALS, INC. | Director | Common Stock Options | 2.92K | May 21, 2024 | Direct | ||
| LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 0 | Dec 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| (LUMO) | LUMOS PHARMA, INC. | Dec 12, 2024 | 8 | $0 | 4 | Dec 13, 2024 | Director |
| ENGN | enGene Holdings Inc. | Jun 15, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| (LUMO) | LUMOS PHARMA, INC. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| INO | INOVIO PHARMACEUTICALS, INC. | May 21, 2024 | 2 | $0 | 4 | May 22, 2024 | Director |
| INO | INOVIO PHARMACEUTICALS, INC. | May 15, 2024 | 2 | $0 | 4 | May 16, 2024 | Director |
| ENGN | enGene Holdings Inc. | Mar 21, 2024 | 1 | $0 | 4 | Mar 25, 2024 | Director |
| ETNB | 89bio, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 5, 2024 | Director |
| ENGN | enGene Holdings Inc. | Dec 18, 2023 | 0 | $0 | 3 | Dec 19, 2023 | Director |
| INO | INOVIO PHARMACEUTICALS, INC. | Jun 5, 2023 | 1 | -$3.19K | 4 | Jun 5, 2023 | Director |
| INO | INOVIO PHARMACEUTICALS, INC. | May 15, 2023 | 4 | $0 | 4 | May 16, 2023 | Director |
| LUMO | LUMOS PHARMA, INC. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
| ETNB | 89bio, Inc. | Feb 9, 2023 | 1 | $0 | 4 | Feb 13, 2023 | Director |
| ZYME | Zymeworks Inc. | Dec 21, 2022 | 1 | $0 | 4 | Dec 23, 2022 | Director |
| ETNB | 89bio, Inc. | May 16, 2022 | 1 | $0 | 4 | May 18, 2022 | Director |
| INO | INOVIO PHARMACEUTICALS, INC. | May 13, 2022 | 5 | -$7.13K | 4 | May 17, 2022 | Director |
| LUMO | LUMOS PHARMA, INC. | May 5, 2022 | 1 | $0 | 4 | May 9, 2022 | Director |
| INO | INOVIO PHARMACEUTICALS, INC. | Jan 3, 2022 | 3 | -$4.81K | 4 | Jan 5, 2022 | Director |
| LUMO | LUMOS PHARMA, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |
| INO | INOVIO PHARMACEUTICALS, INC. | May 13, 2021 | 5 | -$13.5K | 4 | May 17, 2021 | Director |
| ZYME | Zymeworks Inc. | May 6, 2021 | 1 | $0 | 4 | May 7, 2021 | Director |